Ledger.Open graph →

SEC Form D · filed April 27, 2018

SeqOnce BioSciences, Inc

Offering

$1.2M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PASADENA, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Christopher Angermayer · Pasadena, CAExec · Director Joseph Dunham · Pasadena, CADirector Michael Giardello · PASADENA, CADirector Michael Giardello · PASADENA, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗